Literature DB >> 6429565

Phenytoin pharmacokinetics in catamenial epilepsy.

G Shavit, P Lerman, A D Korczyn, S Kivity, M Bechar, S Gitter.   

Abstract

It is not known why the frequency of seizures sometimes increases in the perimenstrual period (catamenial epilepsy). We have examined the possibility that changes in anticonvulsant pharmacokinetics may be responsible. Seventeen women with seizures who were taking phenytoin (DPH) and whose seizures were more frequent perimenstrually were examined twice each, once on the first or second menstrual day and again after 2 weeks. Mean serum DPH levels were lower during the menses. In seven women with seizures unrelated to menses, the fall of DPH levels was much smaller. In catamenial epilepsy, the fall was due to increased DPH clearance. At the time of ovulation, hepatic DPH metabolism may be slowed by competition from steroid hormones.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429565     DOI: 10.1212/wnl.34.7.959

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

Authors:  B Bruguerolle; M Toumi; F Faraj; D Vervloet; H Razzouk
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Variability in the bioavailability of phenytoin capsules in males and females.

Authors:  M C Meyer; A B Straughn; R M Mhatre; V P Shah; M L Chen; R L Williams; L J Lesko
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

Review 3.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

Review 4.  Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.

Authors:  Valérie A Damoiseaux; Johannes H Proost; Vincent C R Jiawan; Barbro N Melgert
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

5.  Interictal spike frequency varies with ovarian cycle stage in a rat model of epilepsy.

Authors:  James D'Amour; Alejandra Magagna-Poveda; Jillian Moretto; Daniel Friedman; John J LaFrancois; Patrice Pearce; Andre A Fenton; Neil J MacLusky; Helen E Scharfman
Journal:  Exp Neurol       Date:  2015-04-10       Impact factor: 5.330

Review 6.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 7.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

Review 9.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

10.  The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients.

Authors:  J Bauer; L Wildt; D Flügel; H Stefan
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.